08.06.14
IGM Resins, Inc., a leader in the development, manufacture and supply of products and technical services to the global UV ink and coatings industry (a portfolio company of Arsenal Capital Partners), has acquired Insight High Technology (IHT) Group. IHT is the leading manufacturer of photoinitiators, pharmaceutical intermediates and fine chemicals in China with strengths in technology innovation, scale-up and production.
“We are very pleased that our long-time partner, IHT, has joined IGM,” said IGM Resins CEO Edward Frindt. “Their great strength in development of new materials, manufacturing capabilities and position in the Asia UV market combined with IGM’s market strength in the rest of the world creates a powerful organization offering depth and breadth of products and technical service to our global customers. We also are committed to supporting the pharmaceutical intermediates business, as we have developed strong partnerships and working relationships in this area.”
“The union with IHT further strengthens IGM’s global position as a leader in photoinitiators and pharmaceutical intermediates,” said Sal Gagliardo, IGM Chairman and Operating Partner of Arsenal Capital Partners.
“IGM and IHT will increase the pace of development of new materials for UV through a joint effort amongst our technical centers in China, Europe and the U.S.,” Andrew Chambers, VP of EMEA and Global PI Manager, said. Products will be consolidated under IGM’s Omnipol, Omnirad and Omnicat brands.
“We are very pleased that our long-time partner, IHT, has joined IGM,” said IGM Resins CEO Edward Frindt. “Their great strength in development of new materials, manufacturing capabilities and position in the Asia UV market combined with IGM’s market strength in the rest of the world creates a powerful organization offering depth and breadth of products and technical service to our global customers. We also are committed to supporting the pharmaceutical intermediates business, as we have developed strong partnerships and working relationships in this area.”
“The union with IHT further strengthens IGM’s global position as a leader in photoinitiators and pharmaceutical intermediates,” said Sal Gagliardo, IGM Chairman and Operating Partner of Arsenal Capital Partners.
“IGM and IHT will increase the pace of development of new materials for UV through a joint effort amongst our technical centers in China, Europe and the U.S.,” Andrew Chambers, VP of EMEA and Global PI Manager, said. Products will be consolidated under IGM’s Omnipol, Omnirad and Omnicat brands.